Proteoglycans especially glypican-1 (GPC1), which enriched on cancer-cell-derived exosomes, may play a role as a biomarker to detect early stages of pancreatic cancer (Melo et al., 2015). This evidence concerns the gene GPC1 and familial pancreatic carcinoma.